Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

JetStream Atherectomy for the Treatment of In-stent Restenosis

ClinicalTrials.gov ID: NCT02730234

Public ClinicalTrials.gov record NCT02730234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 11:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

JetStream Atherectomy for the Treatment of In-stent Restenosis of the Femoropopliteal Artery

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test the hypothesis that Jetstream atherectomy (JS) and adjunctive balloon angioplasty (PTA) (JS +PTA) improves target lesion revascularization (TLR) at 6 months follow-up when compared to historic data from PTA alone in the treatment of femoropopliteal (FP) arterial In-stent restenotic (ISR) disease. This is a prospective, multicenter, single arm study evaluating the investigational use of Jetstream Atherectomy (JS) and adjunctive balloon angioplasty (JS +PTA) in the treatment of FP ISR lesions in subjects with claudication or limb ischemia (Rutherford clinical category (RCC) of 2-4) (lesion length ≥ 4 cm). The comparator arm is historic data from plain old balloon angioplasty derived from a Meta-analysis of the 3 published randomized trials in the field.

Study identification

NCT ID
NCT02730234
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Enrollment
60 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2016 (Type not available)
Primary completion
Feb 4, 2020 (Actual)
Completion
Sep 24, 2020 (Actual)
Last update posted
Aug 11, 2021

2016 – 2020

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Eastern Colorado Healthcare System Denver Colorado 80220 —
Florida Hospital Heartland Medical Center Sebring Florida 33872 —
Advocate Health Downers Grove Illinois 60515 —
Midwest Cardiovascular Research Foundation/Trinity Medical Center Bettendorf Iowa 52722 —
Midwest Cardiovascular Research Foundation/Genesis Medical Center Davenport Iowa 52722 —
Endovascular Technologies, LLC Shreveport Louisiana 71103 —
Atlantic Medical Imaging Galloway New Jersey 08205 —
New Mexico Heart Institute Albuquerque New Mexico 87101 —
Promedica Toledo Hospital Toledo Ohio 43606 —
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 —
US Departmetn of Veterans Affairs, Oklahoma VA Medical Center Oklahoma City Oklahoma 73104 —
Medical University of South Carolina Charleston South Carolina 29425 —
VA North Texas Health Care System: Dallas VA Medical Center Dallas Texas 75216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02730234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02730234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →